+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A multimodal biomarker for concussion identification, prognosis and management

A multimodal biomarker for concussion identification, prognosis and management

Computers in Biology and Medicine 102: 95-103

Prompt, accurate, objective assessment of concussion is crucial, particularly for children/adolescents and young adults. While there is currently no gold standard for the diagnosis of concussion, the importance of multidimensional/multimodal assessments has recently been emphasized. Concussed subjects (N = 177), matched controls (N = 187) and healthy volunteers (N = 204) represented a convenience sample of male and female subjects between the ages of 13 and 25 years, enrolled at 29 Colleges and 19 High Schools in the US. Subjects were tested at time of injury and at multiple time points during recovery. Assessments included EEG, neurocognitive tests and standard concussion assessment tools. Multimodal classifiers to maximally separate controls from concussed subjects with prolonged recovery (≥14 days) were derived using quantitative EEG, neurocognitive and vestibular measures, informed feature reduction and a Genetic Algorithm methodology for classifier derivation. The methodology protected against overtraining using an internal cross-validation framework. An enhanced multimodal Brain Function Index (eBFI) was derived from the classifier output and mapped to a percentile scale which expressed the index relative to non-injured controls. At time of injury eBFIs were significantly different between controls and concussed subjects with prolonged recovery, showing return to non-concussed levels at return-to-play plus 45 days. For the combined concussed population, and for the short recovery subjects, a more rapid recovery was seen. This multivariate, multimodal, objective index of brain function impairment can potentially be used, along with other tools, to aid in diagnosis, assessment, and tracking of recovery from concussion.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 065686614

Download citation: RISBibTeXText

PMID: 30261405

DOI: 10.1016/j.compbiomed.2018.09.011

Related references

The young brain and concussion: imaging as a biomarker for diagnosis and prognosis. Neuroscience and Biobehavioral Reviews 36(6): 1510-1531, 2012

Multimodal evaluation and management of children with concussion: using our heads and available evidence. Brain Injury 29(2): 195-206, 2015

Concussion BASICS III: Serum biomarker changes following sport-related concussion. Neurology 91(23): E2133, 2018

Brain network activation (bna) analysis as a biomarker for concussion assessment and management. British Journal of Sports Medicine 51(11): A2.2-A2, 2017

The use of telomere length as a predictive biomarker for injury prognosis in juvenile rats following a concussion/mild traumatic brain injury. Neurobiology of Disease 87: 11-18, 2016

A systematic review of the biomarker S100B: implications for sport-related concussion management. Journal of Athletic Training 49(6): 830-850, 2014

Theta-Band Functional Connectivity and Single-Trial Cognitive Control in Sports-Related Concussion: Demonstration of Proof-of-Concept for a Potential Biomarker of Concussion. Journal of the International Neuropsychological Society 25(3): 314-323, 2019

Speech-language pathology and concussion management in intercollegiate athletics: the Miami University Concussion Management Program. American Journal of Speech-Language Pathology 23(4): 507-519, 2014

Multi-biomarker pattern for tumor identification and prognosis. Journal of Cellular Biochemistry 112(10): 2703-2715, 2011

Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma. Cancer Biomarkers 21(2): 449-454, 2018

Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma. European Review for Medical and Pharmacological Sciences 21(3): 518-522, 2017

Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer. Journal of Histochemistry and Cytochemistry 63(12): 922-930, 2015

Concussion Subtype Identification With the Rivermead Post-concussion Symptoms Questionnaire. Frontiers in Neurology 9: 1034, 2018

Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma. Journal of International Medical Research 40(6): 2090-2097, 2012

Identification of Five Genes as a Potential Biomarker for Predicting Progress and Prognosis in Adrenocortical Carcinoma. Journal of Cancer 9(23): 4484-4495, 2018